690261-64-4 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
2-(Piperidin-4-yl)pyrimidine hydrochloride is used as a chemical probe for modulating biological targets such as receptors and enzymes, facilitating the discovery and optimization of new therapeutic agents.
Used in Cancer Therapy:
In the field of oncology, 2-(Piperidin-4-yl)pyrimidine hydrochloride is used as a potential therapeutic agent for the treatment of various types of cancer, leveraging its ability to interact with specific biological targets involved in cancer progression.
Used in Inflammation Management:
2-(Piperidin-4-yl)pyrimidine hydrochloride is employed as an anti-inflammatory agent, potentially modulating the activity of enzymes or receptors that contribute to inflammatory responses.
Used in Neurological Disorders:
2-(Piperidin-4-yl)pyriMidine hydrochloride is utilized in the research and development of treatments for neurological disorders, given its potential to target specific pathways or receptors implicated in such conditions.
Used in the Formulation of Stable Pharmaceutical Products:
Due to its enhanced stability and solubility in water as a hydrochloride salt, 2-(Piperidin-4-yl)pyrimidine hydrochloride is used in the formulation of pharmaceutical products to improve their shelf life and bioavailability.
Check Digit Verification of cas no
The CAS Registry Mumber 690261-64-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,0,2,6 and 1 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 690261-64:
(8*6)+(7*9)+(6*0)+(5*2)+(4*6)+(3*1)+(2*6)+(1*4)=164
164 % 10 = 4
So 690261-64-4 is a valid CAS Registry Number.
690261-64-4Relevant academic research and scientific papers
NOVEL COMPOUNDS
-
Page/Page column 37, (2019/03/05)
The invention relates to compounds of Formula (I) and their use in therapy, for example in the treatment of mycobacterial infections or in the treatment of diseases caused by mycobacterium, such as tuberculosis.
Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity
-
Page/Page column 31, (2008/06/13)
The present invention is directed to compounds of the formula I: Wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X, n and the broken lines are as defined herein which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.
HETEROARYLPIPERIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
-
Page 48, (2008/06/13)
The present invention is directed to compounds of the formula (I): (wherein R>12345610 and n are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.
HETEROCYCLIC CYCLOPENTYL TETRAHYDROISOQUINOLINE AND TETRAHYDROPYRIDOPYRIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
-
Page 72, (2008/06/13)
The present invention is directed to compounds of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X, n and the broken lines are as defined herein which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.
